Pathology/Lab Coding Alert

CPT 2005:

Here's How to Use the New B, NK and Stem Cell Codes

They're not for hematolymphoid phenotyping CPT 2005 adds three new immunology codes for cell markers. But don't let the codes fool you - you should only use the new codes for clinical hematologic tests with no professional interpretation, not for flow-cytometric immunophenotyping to assess potential hematolymphoid neoplasia:

86064 - B cells, total count
86379 - Natural killer (NK) cells, total count
86587 - Stem cells (i.e., CD34), total count. A CPT text note following the codes states, "For flow cytometric immunophenotyping for the assessment of potential hematolymphoid neoplasia, see 88182, 88184-88189." (Except the note following 86587 specifies, "see 88182, 88189.") Same Cell Markers Used for Immunology, Neoplasm Immunophenotyping Physicians may order B cell, NK cell, or stem cell studies for disparate reasons, such as to monitor immune response in HIV patients or to assess potential hematolymphoid neoplasia in cancer patients. To select the proper code, you need to know why the physician ordered the test and whether the pathologist interprets the results for neoplasia immunophenotyping.

"Depending on whether the lab performs immunologic tests for these cells to evaluate conditions such as immunodeficiency, or performs flow-cytometry cell analysis to aid in cancer diagnosis, you should report the cell studies using a different set of codes in the CPT book - immunology in the 86000s, and flow cytometry in the 88000s," says William Dettwyler, MT-AMT, president of Codus Medicus, a laboratory coding consulting firm in Salem, Ore. Clinical Lab Fee Schedule Pays Immunology Codes Labs often perform clinical cell analyses to evaluate immunodeficiency using test kits or immunologic methods that may involve flow cytometry. These tests don't require an interpretive report. "That's when you should use 86000 codes, such as T cells (86359, T cells; total count), B cells (86064), NK cells (86379), or stem cells (86587)," Dettwyler says.

Medicare will pay for new codes 86064, 86379, and 86587 under the Clinical Laboratory Fee Schedule (CLFS), and the agency has crosswalked the codes to existing CPT 86359 . That means you'll see about $52.70 (National Fee Cap) for each B cell, NK cell, or stem cell test. Because these are CLFS codes, they represent a technical clinical-lab service with no separately billable professional component for test-result interpretation. Physician Fee Schedule Pays Flow Cytometry Codes Pathologists often evaluate a series of cell markers using flow cytometry to type and classify different types of lymphomas and leukemias - and that's when you should use the flow cytometry codes.

Example: The pathologist may interpret a leukemia panel that involves 10 markers including CD34 (stem cells) and B cells.

Old way: Before CPT 2005 introduced new flow cytometry codes, you may have reported this service as 88180 x 10 (deleted in 2005: 88180, Flow cytometry; each cell surface, [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.